Medline Inc. (MDLN)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Front Line Care Revenue	6.61B	6.51B	6.09B
Front Line Care Revenue Growth	1.47%	7.00%	4.16%
Surgical Solutions Revenue	6.35B	6.17B	5.47B
Surgical Solutions Revenue Growth	2.92%	12.70%	10.95%
Laboratory and Diagnostics Revenue	1.11B	1.04B	956.00M
Laboratory and Diagnostics Revenue Growth	6.35%	8.79%	14.22%
Medline Brand Revenue	13.91B	13.72B	12.52B
Medline Brand Revenue Growth	1.35%	9.63%	7.77%
Supply Chain Solutions Revenue	15.15B	14.71B	12.99B
Supply Chain Solutions Revenue Growth	2.95%	13.24%	11.83%
Revenue (Other)	89.00M	-	-
Revenue (Total)	29.14B	28.43B	25.51B
Revenue (Total) Growth	2.49%	11.47%	9.80%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
United States Revenue	27.00B	26.48B	23.75B
United States Revenue Growth	1.96%	11.51%	8.93%
International Revenue	1.95B	1.95B	1.76B
International Revenue Growth	-0.05%	10.97%	22.99%
Revenue (Other)	189.00M	-	-
Revenue (Total)	29.14B	28.43B	25.51B
Revenue (Total) Growth	2.49%	11.47%	9.80%

Adjusted EBITDA

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Medline Brand Adjusted EBITDA	3.20B	3.33B	3.27B
Medline Brand Adjusted EBITDA Growth	-3.93%	1.99%	20.89%
Supply Chain Solutions Adjusted EBITDA	777.00M	805.00M	647.00M
Supply Chain Solutions Adjusted EBITDA Growth	-3.48%	24.42%	31.77%
Operating Income (Total)	2.06B	2.21B	2.15B
Operating Income (Total) Growth	-6.74%	3.08%	71.68%

Updated May 6, 2026. Data Source: Fiscal.ai.